ArticleExploration of targeted anti-tumor therapy2024

Response to trametinib, hydroxychloroquine, and bevacizumab in a young woman with

Aram A Musaelyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.